E. Petersdorf

发表

Nomenclature for factors of the HLA system, 2010

W. Bodmer, P. Parham, J. Trowsdale, 2010, Tissue antigens.

E. Petersdorf, 2015, Blood.

High HLA-DP Expression and Graft-versus-Host Disease.

Effie W Petersdorf, Mari Malkki, Mary Carrington, 2015, The New England journal of medicine.

Tegument-Specific, Virus-Reactive CD4 T Cells Localize to the Cornea in Herpes Simplex Virus Interstitial Keratitis in Humans

W. Kwok, E. Petersdorf, D. Koelle, 2000, Journal of Virology.

Risk of Cervical Cancer Associated with Allergies and Polymorphisms in Genes in the Chromosome 5 Cytokine Cluster

S. Schwartz, D. Galloway, M. Malkki, 2010, Cancer Epidemiology, Biomarkers & Prevention.

The MHC in the era of next-generation sequencing: Implications for bridging structure with function.

E. Petersdorf, C. O'huigin, C. O’hUigin, 2019, Human immunology.

Tumor necrosis factor polymorphism affects transplantation outcome in patients with myelodysplastic syndrome but not in those with chronic myelogenous leukemia, independent of the presence of HLA-DR15.

D. Stirewalt, J. Hansen, E. Petersdorf, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Which factors influence the development of GVHD in HLA-matched or mismatched transplants?

E. Petersdorf, 2017, Best practice & research. Clinical haematology.

Optimal HLA matching in hematopoietic cell transplantation.

E. Petersdorf, 2008, Current opinion in immunology.

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

J. Chewning, K. Hsu, B. Dupont, 2012, The New England journal of medicine.

HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.

J. Klein, Stephanie J. Lee, O. Ringdén, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.

K. Hsu, M. Malkki, S. Spellman, 2010, Blood.

KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.

F. Christiansen, A. Gratwohl, K. Hsu, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.

K. Hsu, B. Dupont, M. Malkki, 2007, Tissue antigens.

Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy of EBV+ Hodgkin's disease.

P. Greenberg, E. Petersdorf, R. Ambinder, 1997, Blood.

The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.

A. Begovich, J. Madrigal, A. Gratwohl, 2007, Blood.

The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.

A. Begovich, J. Madrigal, A. Gratwohl, 2007, Blood.

Genetics of risk factors for graft-versus-host disease.

M. Malkki, E. Petersdorf, 2006, Seminars in hematology.

MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies.

G Thomson, M. Carrington, G. Thomson, 2005, Tissue antigens.

Chapter 2 Stem Cell Transplantation for Hematologic Malignancies

E. Petersdorf, 2008 .

Stem Cell Transplantation for Hematologic Malignancies

E. Petersdorf, 2008 .

MHC class I, II, and III microsatellite marker matching and survival in unrelated donor hematopoietic cell transplantation.

M. Horowitz, M. Malkki, E. Petersdorf, 2007, Tissue antigens.

Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.

H. Deeg, R. Storb, B. Sandmaier, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis.

S. Lewis, A. Diehl, C. Mungall, 2010, Human molecular genetics.

Hematopoietic stem cell transplants from unrelated donors

J. Hansen, E. Petersdorf, C. Anasetti, 1997, Immunological reviews.

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.

R. Storb, B. Storer, F. Appelbaum, 2011, Blood.

Duration of immunosuppressive treatment for chronic graft-versus-host disease.

R. Storb, B. Storer, F. Appelbaum, 2004, Blood.

Hematopoietic Cell Transplantation from Unrelated Donors

E. Petersdorf, 2009 .

Design and Implementation of the International Genetics and Translational Research in Transplantation Network

Graham M Lord, Jason H. Moore, W. Guan, 2015, Transplantation.

Patient HLA Germline Variation and Transplant Survivorship.

R. Strong, M. Horowitz, M. Malkki, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

malignancies nonmyeloablative conditioning for patients with hematologic HLA-matched unrelated donor hematopoietic cell transplantation after

S. Heimfeld, M. Maris, B. Sandmaier, 2013 .

Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.

M. Sorror, R. Storb, B. Sandmaier, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.

C. Kollman, E. Petersdorf, D. Weisdorf, 2002, Blood.

Trends in transplantation of hematopoietic stem cells from unrelated donors.

J. Hansen, E. Petersdorf, C. Anasetti, 2001, Current opinion in hematology.

Oligonucleotide arrays for high-throughput SNPs detection in the MHC class I genes: HLA-B as a model system.

L. Hood, J. Hansen, E. Petersdorf, 2002, Genome research.

Cervical and Vulvar Cancer Risk in Relation to the Joint Effects of Cigarette Smoking and Genetic Variation in Interleukin 2

S. Schwartz, D. Galloway, M. Malkki, 2008, Cancer Epidemiology Biomarkers & Prevention.

Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.

R. Storb, F. Appelbaum, J. Hansen, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.

H. Deeg, R. Storb, F. Appelbaum, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.

B. Storer, Anajane G. Smith, J. Hansen, 2001, The New England journal of medicine.

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.

D. Porter, M. Horowitz, K. Hsu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

New advances in hematopoietic cell transplantation

J. Hansen, E. Petersdorf, 2008, Current opinion in hematology.

Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation.

M. Malkki, E. Petersdorf, 2005, Seminars in hematology.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.

B. Storer, G. Armstrong, S. Bhatia, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Research Methodology and Study Design

B. Storer, S. Bhatia, B. Shaw, 2016 .

Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus.

Pepe, M. Pepe, G. Longton, 1993, Blood.

What do transplant physicians think about palliative care? A national survey study

W. Wood, A. El-Jawahri, T. Leblanc, 2017, Cancer.

Marrow transplantation from unrelated volunteer donors.

Ruth Etzioni, J. Hansen, E. Petersdorf, 1995, Annual review of medicine.

Marrow transplantation from unrelated volunteer donors.

E. Petersdorf, C. Anasetti, P. Martin, 1995, Cancer treatment and research.

Role of HLA-B Exon 1 in Graft-versus-Host Disease After Unrelated Donor Transplantation: A Retrospective Cohort Study

K. Hsu, M. Maiers, M. Malkki, 2020 .

HLA-B Leader and Survivorship after HLA-Mismatched Unrelated Donor Transplantation.

M. Carrington, M. Horowitz, K. Hsu, 2020, Blood.

S. Spellman, M. Fernandez-Vina, C. Hurley, 2013 .

Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes

Ming-Tseh Lin, B. Storer, J. Hansen, 2008, Immunologic research.

Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors.

M. Malkki, E. Petersdorf, Y. Morishima, 2007, Tissue antigens.

High Resolution Donor HLA-Matching: Saving Lives

E. Petersdorf, 2006 .

HLA matching in allogeneic stem cell transplantation

E. Petersdorf, 2004, Current opinion in hematology.

Tissue typing in support of unrelated hematopoietic cell transplantation.

J. Hansen, E. Petersdorf, C. Anasetti, 2003, Tissue antigens.

Impact of molecular histocompatibility typing on outcome of unrelated donor hematopoietic cell transplantation

J. Hansen, E. Petersdorf, C. Anasetti, 2002 .

Genomics of unrelated-donor hematopoietic cell transplantation.

Ming-Tseh Lin, Anajane G. Smith, J. Hansen, 2001, Current opinion in immunology.

The biological significance of HLA‐DP gene variation in haematopoietic cell transplantation

Anajane G. Smith, J. Hansen, M. Malkki, 2001, British journal of haematology.

Improving availability and safety of unrelated donor transplants

J. Hansen, E. Petersdorf, C. Anasetti, 2000, Current opinion in oncology.

HLA matching in hematopoietic cell transplantation.

J. Hansen, E. Petersdorf, C. Anasetti, 2000, Human immunology.

Transplantation of hematopoietic stem cells from unrelated volunteer donors.

J. Hansen, E. Petersdorf, C. Anasetti, 2000, Transplantation proceedings.

J. Hansen, E. Petersdorf, C. Anasetti, 1999, Cancer treatment and research.

Definition of HLA-DQ as a transplantation antigen.

G. Longton, Anajane G. Smith, J. Hansen, 1996, Proceedings of the National Academy of Sciences of the United States of America.

The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation.

G. Longton, Anajane G. Smith, J. Hansen, 1995, Blood.

A comprehensive approach for typing the alleles of the HLA-B locus by automated sequencing.

J. Hansen, E. Petersdorf, 1995, Tissue antigens.

Analysis of HLA-B*44 alleles encoded on extended HLA haplotypes by direct automated sequencing.

J. Hansen, A. Smith, E. Petersdorf, 1994, Tissue antigens.

HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation.

K. Hsu, E. Petersdorf, T. Gooley, 2020, Blood advances.

HLA-A alleles in ﬂ uencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation

K. Hsu, E. Petersdorf, T. Gooley, 2020 .

Identification of the rs9277534 HLA-DP expression marker by next generation sequencing for the selection of unrelated donors for hematopoietic cell transplantation.

J. Hansen, E. Petersdorf, L. Regen, 2019, Human immunology.

Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression

M. Carrington, D. Roelen, F. Claas, 2014, Front. Immunol..

Identification of a novel HLA-C allele, Cw*0406, in a Singapore Malay.

E. Petersdorf, E. Ren, S. Chan, 1999, Tissue antigens.

Molecular diversity of the HLA-C locus in unrelated marrow transplantation.

J. Hansen, E. Petersdorf, P. Martin, 1994, Tissue antigens.

Seven new DPB1 alleles and their population distribution.

A. Hill, A. Begovich, E. Petersdorf, 1994, Tissue antigens.

HLA-DRB1 first domain sequences of two new DR11 alleles and one novel DR4 allele.

J. Hansen, A. Smith, E. Petersdorf, 1993, Tissue antigens.

HLA-DRB1 first domain sequence for a novel DR4 allele designated DRB1*0413.

J. Hansen, A. Smith, E. Petersdorf, 1992, Tissue antigens.

HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling.

J. Hansen, E. Petersdorf, T. Gooley, 1998, Biology of Blood and Marrow Transplantation.

HLA homozygosity and the risk of graft-versus-host disease.

J. Hansen, E. Petersdorf, C. Anasetti, 1997, Tissue antigens.

Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.

M. Pepe, K. Sullivan, R. Storb, 1991, Transplantation.

Allogeneic hematopoietic stem cell transplantation for myelofibrosis.

H. Deeg, J. Radich, R. Storb, 2003, Blood.

Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.

H. Deeg, P. Hari, K. Ballen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient.

Anajane G. Smith, J. Hansen, A. Smith, 1998, Blood.

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

J. Klein, M. Horowitz, P. Cano, 2013, Blood.

Association between pretransplant interferon-α and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase

K. Sullivan, R. Storb, F. Appelbaum, 1998 .

Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.

K. Sullivan, R. Storb, F. Appelbaum, 1998, Blood.

One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.

J. Sierra, Stephanie J. Lee, O. Ringdén, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry.

M. Maiers, S. Spellman, M. Fernandez-Vina, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Histocompatibility matching for bone marrow transplantation. Donor-recipient pairs in the 4AOHW cell panel.

F. Christiansen, C. Witt, E. Petersdorf, 1993, Human immunology.

Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.

H. Deeg, F. Appelbaum, E. Petersdorf, 2004, Leukemia research.

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, Blood.

TRANSPLANTATION Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013 .

BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning

R. Brand, D. Niederwieser, U. Hegenbart, 2004, Leukemia.

HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.

A. Nademanee, J. Klein, M. Horowitz, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.

E. Reed, J. Boudreau, K. Hsu, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biobehavioral research and hematopoietic stem cell transplantation: Expert review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and Cellular Therapy.

W. Wood, H. Jim, K. Syrjala, 2021, Transplantation and cellular therapy.

Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen mismatched donors.

M. Maris, R. Storb, B. Sandmaier, 2020, Blood.

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

A. Barrett, M. Horowitz, J. Wingard, 2009, Blood.

Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia

J. Klein, Stephanie J. Lee, S. Spellman, 2012, Haematologica.

Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal women.

B. McKnight, M. Malkki, E. Petersdorf, 2013, International journal of molecular epidemiology and genetics.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2018, Haematologica.

Oligonucleotide arrays for high resolution HLA typing.

Z. Guo, L. Hood, E. Petersdorf, 1999, Reviews in immunogenetics.

Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.

D. Neuberg, K. Sullivan, E. Petersdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Identification of the MICA*070 allele by sequencing and phasing.

M. Malkki, E. Petersdorf, S. Morishima, 2013, Human immunology.

Allogeneic hematopoietic stem cell transplantation for myeloﬁbrosis

H. Deeg, J. Radich, R. Storb, 2003 .

Race and Survival in Unrelated Hematopoietic-cell Transplantation.

Y. Kodera, M. Malkki, S. Spellman, 2022, Transplantation and cellular therapy.

Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation.

G. Longton, J. Hansen, E. Petersdorf, 1996, Tissue antigens.

Immune response gene polymorphisms in unrelated donor hematopoietic cell transplantation.

M. Horowitz, M. Malkki, E. Petersdorf, 2007, Tissue antigens.

Secondary T-cell lymphoproliferation after marrow transplantation.

R. Hackman, E. Petersdorf, M. Zutter, 1990, American journal of clinical pathology.

Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors.

H. Deeg, K. Sullivan, R. Storb, 1994, Blood.

Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation.

J. Hansen, A. Smith, E. Petersdorf, 2001, Blood.

transplantation superior to HLA-identical siblings for hematopoietic stem cell The graft-versus-leukemia effect using matched unrelated donors is not

J. Wingard, P. McCarthy, S. Spellman, 2011 .

Marrow transplants from HLA matched unrelated donors: an NMDP update and the Seattle experience.

J. Hansen, E. Petersdorf, C. Anasetti, 1994, Bone marrow transplantation.

ncreasingly Frequent Diagnosis of Acute astrointestinal Graft-versus-Host Disease after llogeneic Hematopoietic Cell Transplantation

R. Storb, F. Appelbaum, J. Hansen, 2004 .

Allogeneic marrow transplantation

J. Hansen, E. Petersdorf, C. Anasetti, 1993 .

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.

M. Sorror, M. Maris, R. Storb, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genomic polymorphism and allogeneic hematopoietic transplantation outcome.

C. Mullighan, E. Petersdorf, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nomenclature for factors of the HLA system, 2000.

J. Bodmer, W. Bodmer, P. Parham, 2001, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Long-range multilocus haplotype phasing of the MHC.

Effie W Petersdorf, Mari Malkki, L. Hood, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Variations on the theme of human leukocyte antigen and killer cell immunoglobulin-like receptors

E. Petersdorf, 2005 .

Effect of HLA mismatches on the outcome of hematopoietic transplants.

J. Hansen, E. Petersdorf, C. Anasetti, 1999, Current opinion in immunology.

Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach

F. M. Stewart, B. Sandmaier, F. Appelbaum, 2020, Bone Marrow Transplantation.

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.

B. Storer, F. Appelbaum, J. Hansen, 2002, Blood.

The World Marrow Donor Association: Twenty Years of International Collaboration for the Support of Unrelated Donor and Cord Blood Hematopoietic Cell Transplantation

E. Petersdorf, Effie W. Petersdorf, 2010, Bone Marrow Transplantation.

Structural Studies of Allelic Diversity of the MHC Class I Homolog MIC-B, a Stress-Inducible Ligand for the Activating Immunoreceptor NKG2D1

R. Strong, M. Holmes, E. Petersdorf, 2002, The Journal of Immunology.

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

J. Klein, M. Horowitz, J. Wingard, 2014, Clinical Cancer Research.

HLA Typing in Support of Hematopoietic Cell Transplantation from Unrelated Donors

J. Hansen, E. Petersdorf, C. Anasetti, 2013 .

Genotyping of single nucleotide polymorphisms by 5' nuclease allelic discrimination.

M. Malkki, E. Petersdorf, 2012, Methods in molecular biology.

Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain

Anajane G. Smith, J. Hansen, E. Petersdorf, 2004, Immunogenetics.

Unique sequences for two HLA-DRB1 genes expressed on distinct DRw6 haplotypes

H. Erlich, Anajane G. Smith, J. Hansen, 2004, Immunogenetics.

Polymorphism of HLA-DRw52-associated DRB1 genes as defined by sequence-specific oligonucleotide probe hybridization and sequencing.

Anajane G. Smith, J. Hansen, A. Smith, 1991, Tissue antigens.

Genetics of graft-versus-host disease: the major histocompatibility complex.

Effie W Petersdorf, E. Petersdorf, 2013, Blood reviews.

Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation

E. Petersdorf, 2017, F1000Research.

The major histocompatibility complex: a model for understanding graft-versus-host disease.

E. Petersdorf, 2013, Blood.

MHC Haplotype Matching for Unrelated Hematopoietic Cell Transplantation

Effie W Petersdorf, Mari Malkki, M. Malkki, 2007, PLoS medicine.

Immunogenomics of unrelated hematopoietic cell transplantation.

E. Petersdorf, 2006, Current opinion in immunology.

Nomenclature for factors of the HLA system, 2000.

W R Mayr, J G Bodmer, S G Marsh, 2001, Human immunology.

Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.

H. Deeg, K. Sullivan, R. Storb, 1997, Blood.

Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation.

M. Horowitz, M. Malkki, S. Spellman, 2013, Blood.

TRANSPLANTATION Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation

M. Malkki, S. Spellman, Tao Wang, 2013 .

MHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation

M. Horowitz, M. Malkki, S. Spellman, 2012, Science Translational Medicine.

Mapping MHC-resident transplantation determinants.

F. Christiansen, M. Horowitz, M. Malkki, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk assessment in haematopoietic stem cell transplantation: histocompatibility.

E. Petersdorf, 2007, Best practice & research. Clinical haematology.

The HLA system in hematopoietic stem cell transplantation

E. Petersdorf, D. Charron, 2013 .

IL10 and IL10 Receptor Gene Variation and Outcomes After Unrelated and Related Hematopoietic Cell Transplantation

L. Zhao, Ming-Tseh Lin, B. Storer, 2009, Transplantation.

Nucleotide variation in IL‐10 and IL‐12 and their receptors and cervical and vulvar cancer risk: A hybrid case–parent triad and case–control study

S. Schwartz, D. Galloway, M. Malkki, 2013, International journal of cancer.

A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.

S. Schwartz, D. Galloway, M. Malkki, 2015, Gynecologic oncology.

Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.

S. Schwartz, M. Malkki, E. Petersdorf, 2012, Gynecologic oncology.

In celebration of Ruggero Ceppellini: HLA in transplantation

E. Petersdorf, 2017, HLA.

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

M. Carrington, C. Witt, R. Apps, 2014, Blood.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

Medhat Askar, Effie W Petersdorf, Kwang Woo Ahn, 2014, Blood.

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Effie W Petersdorf, Mari Malkki, Katharina Fleischhauer, 2012, The Lancet. Oncology.

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Harriet Noreen, Marcelo Fernandez-Vina, John Klein, 2007, Blood.

Limits of HLA mismatching in unrelated hematopoietic cell transplantation.

Effie W Petersdorf, Mari Malkki, Eric Mickelson, 2004, Blood.

From trees to the forest: genes to genomics.

C. Mullighan, J. Dipersio, S. Davies, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

S. Heimfeld, M. Maris, R. Storb, 2003, Blood.

Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer

B. McKnight, K. Malone, M. Malkki, 2011, Breast Cancer Research and Treatment.

An update to HLA Nomenclature, 2010

W R Mayr, D E Geraghty, M Maiers, 2010, Bone Marrow Transplantation.

A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs.

A. Begovich, W. Hildebrand, S. Spellman, 2007, Human immunology.

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Harriet Noreen, Carolyn Hurley, Marcelo Fernandez-Vina, 2004, Blood.

What is the role for donor natural killer cells after nonmyeloablative conditioning?

R. Storb, F. Baron, B. Sandmaier, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marrow Transplants from Unrelated Donors for the Treatment of High-Risk Acute Leukemia

J. Sierra, J. Hansen, E. Petersdorf, 1998 .

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissio

R. Storb, B. Sandmaier, D. Maloney, 2003, Blood.

Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study

B. McKnight, K. Malone, M. Malkki, 2013, BMC Cancer.

Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.

R Storb, C Anasetti, K. Sullivan, 1997, Blood.

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.

Effie W Petersdorf, John Horan, Michelle Setterholm, 2010, Blood.

Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors.

G. Longton, Anajane G. Smith, J. Hansen, 1997, Blood.

K. Sullivan, R. Storb, F. Appelbaum, 1995, Blood.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Alan M. Miller, P. D. Dal Cin, J. Sierra, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.

A. Nademanee, A. Begovich, C. Kollman, 2001, Blood.

Faculty Opinions recommendation of Hunter-gatherer genomic diversity suggests a southern African origin for modern humans.

E. Petersdorf, 2011 .

An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens.

W. Leisenring, E. Petersdorf, G. McDonald, 2006, Blood.

Genetic variation in the TLR and NF‐κB pathways and cervical and vulvar cancer risk: A population‐based case–control study

S. Schwartz, D. Galloway, M. Malkki, 2014, International journal of cancer.

T-cell clones identify three distinct epitopes associated with HLA-Dw14.

J. Hansen, G. Nepom, A. Smith, 1991, Human immunology.

The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age.

D. Miklos, Stephanie J. Lee, S. Spellman, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cord-Blood Transplantation in Patients with Minimal Residual Disease.

B. Wood, M. Sorror, B. Sandmaier, 2016, The New England journal of medicine.

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.

C Anasetti, T A Gooley, J. Radich, 1998, The New England journal of medicine.

Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements.

J. Hansen, E. Petersdorf, C. Anasetti, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA matching and hematopoietic cell transplant outcome.

J. Hansen, E. Petersdorf, E. Mickelson, 2002, Clinical transplants.

Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.

M. Carrington, E. Tholouli, C. Crawley, 2019, The Lancet. Haematology.

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.

M. Aljurf, Stephanie J. Lee, S. Marsh, 2014, Blood.

HLA Informs Risk Predictions after Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide.

Shannon R. McCurdy, M. Grunwald, Stephanie J. Lee, 2021, Blood.

Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

H. Deeg, J. Radich, R. Storb, 2002, Blood.

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.

J. Panse, M. Maris, R. Storb, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

F. Appelbaum, J. Hansen, E. Petersdorf, 1994, Blood.

Clinical importance of HLA-DPB1 in haematopoietic cell transplantation.

B. Shaw, S. Marsh, M. Malkki, 2007, Tissue antigens.

American Society for Blood and Marrow Transplantation guidelines for training.

J. Fay, E. Shpall, E. Petersdorf, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Interleukin‐1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia

J. Klein, M. MacMillan, S. Davies, 2007, British journal of haematology.

cross-reactivity against prevalent HLA class I alleles : Presented in part at specific CD8 cytotoxic T lymphocyte - Herpes simplex virus type 2

E. Petersdorf, D. Koelle, Hongbo Chen, 2013 .

Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I alleles.

E. Petersdorf, D. Koelle, Hongbo Chen, 2002, Blood.

A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.

R. Storb, F. Appelbaum, M. Flowers, 1999, Blood.

Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.

M. Carrington, M. Horowitz, M. Malkki, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: Linkage analysis of over 32,000 samples.

Effie W Petersdorf, Kathrin Lang, Alexander H Schmidt, 2018, Human immunology.

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

J. Klein, Stephanie J. Lee, O. Ringdén, 2008 .

Comparison of Matched Unrelated and Matched Related Donor Myeloablative Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia in First Remission

F. M. Stewart, M. Sorror, F. Appelbaum, 2010, Leukemia.

Nomenclature for factors of the HLA system, 2002.

Effie W Petersdorf, Arne Svejgaard, Peter Parham, 2002, Human immunology.

Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.

F. M. Stewart, M. Sorror, R. Storb, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

16th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation

A. Velardi, M. Malkki, E. Petersdorf, 2012, International journal of immunogenetics.

Nomenclature for factors of the HLA system, 1998.

W R Mayr, J G Bodmer, S G Marsh, 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Nomenclature for Factors of the HLA System, 1998

Arne Svejgaard, Peter Parham, Takehiko Sasazuki, 1999, Tissue antigens.

Population study of allelic diversity in the human MHC class I-related MIC-A gene

G. Longton, J. Hansen, E. Petersdorf, 1999, Immunogenetics.

Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility

M. Thornquist, M. Barnett, G. Goodman, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation

M. Maiers, E. Petersdorf, Yung-Tsi Bolon, 2021, Blood advances.

Use of the HLA-B leader to optimize cord blood transplantation

C. Chabannon, E. Petersdorf, T. Gooley, 2020, Haematologica.

Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.

G. Longton, E. Petersdorf, C. Anasetti, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

I. Yakoub-Agha, E. Tholouli, E. Deconinck, 2022, Haematologica.

E. Petersdorf, 2016, Seminars in hematology.

Effect of HLA matching on outcome of related and unrelated donor transplantation therapy for chronic myelogenous leukemia.

E. Petersdorf, C. Anasetti, P. Martin, 1998, Hematology/oncology clinics of North America.

Nomenclature for Factors of the HLA System, 1998

Julia G. Bodmer, Arne Svejgaard, Peter Parham, 1999, Vox Sanguinis.

Nomenclature for factors of the HLA system, 2002.

W R Mayr, S G E Marsh, D E Geraghty, 2002, Tissue antigens.

14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation

A. Cambon-Thomsen, A. Velardi, J. Hansen, 2007 .

Ten HLA-DR 4 alleles defined by sequence polymorphisms within the DRB 1 first domain

Anajane G. Smith, J. Hansen, E. Petersdorf, 2022 .

The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.

G. Longton, Anajane G. Smith, J. Hansen, 1993, Blood.

The Role of HLA-DPB 1 Disparity in the Development of Acute Graft-Versus-Host Disease Following Unrelated Donor Marrow Transplantation

G. Longton, Anajane G. Smith, J. Hansen, 2003 .

Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.

A. Velardi, M. Malkki, S. Spellman, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nomenclature for Factors of the HLA System, 2004.

Effie W Petersdorf, Arne Svejgaard, Peter Parham, 2005, Human immunology.

Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients.

A. Evens, E. Petersdorf, H. Lazarus, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Chapter 105 – Unrelated Donor Hematopoietic Cell Transplantation

E. Petersdorf, C. Anasetti, 2018 .

Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.

Anajane G. Smith, J. Hansen, A. Smith, 1999, Blood.

Retransplantation of marrow and hematopoietic stem cells from normal donors

J. Radich, J. Hansen, E. Petersdorf, 1997 .

Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors.

C Anasetti, G. Longton, J. Hansen, 1993, Transplantation proceedings.

HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category.

J. Pagel, Stephanie J. Lee, J. Hansen, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Significant differences in outcome following unrelated donor HCT can be better predicted using an algorithm incorporating both allele and epitope level matching for HLA-DPB1

Mari Malkki, Stephen Spellman, Ted Gooley, 2009 .

Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors.

M. Horowitz, M. Malkki, E. Petersdorf, 2007, Tissue antigens.

Identification of a novel HLA-B*07 allele--HLA-B*0726.

M. Malkki, E. Petersdorf, R. McKenna, 2002, Tissue antigens.

Nomenclature for factors of the HLA system, 2004.

W. Bodmer, P. Parham, J. Trowsdale, 2005, International Journal of Immunogenetics.

Nomenclature for factors of the HLA system, 2002.

W. Bodmer, P. Parham, B. Mach, 2002, European journal of immunogenetics.

Nomenclature for factors of the HLA System, 1998.

J. Bodmer, W. Bodmer, P. Parham, 1999, Human Immunology.

HLA-B leader genotypes in a clinical population.

E. Petersdorf, P. Peterson, L. Regen, 2023, HLA.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

J. Klein, M. Horowitz, J. Wingard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autoimmune Diseases : When Homeland Security Fails

Treasurer, J. Dipersio, R. Truitt, 2004 .

Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.

H. Deeg, Emily A. Stevens, M. Sorror, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor NK Cell Engraftment and Overall and Progression-Free Survivals after Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning.

R. Storb, F. Baron, B. Sandmaier, 2005 .

What is the role for donor NK cells after nonmyeloablative conditioning

R. Storb, F. Baron, B. Sandmaier, 2007 .

Marrow transplants from unrelated donors.

J. Sierra, J. Hansen, E. Petersdorf, 1995, Clinical transplants.

IL 10 AND IL 10 RECEPTOR GENE VARIATION AND OUTCOMES AFTER UNRELATED AND RELATED HEMATOPOIETIC CELL TRANSPLANTATION

L. Zhao, Ming-Tseh Lin, B. Storer, 2009 .

Marrow transplantation from HLA partially matched relatives and unrelated donors

J. Hansen, E. Petersdorf, C. Anasetti, 1995 .

regimens after hematopoietic cell transplantation with myeloablative conditioning An acute graft-versus-host disease activity index to predict survival

W. Leisenring, E. Petersdorf, G. McDonald, 2010 .

Risk factors associated with increased grades III-IV acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT)

H. Deeg, M. Sorror, R. Storb, 2006 .

Diagnostic use of molecular probes before and after marrow transplantation.

E. Petersdorf, H. Deeg, 1992, Clinics in laboratory medicine.

Nomenclature for factors of the HLA system, 2004

W R Mayr, D E Geraghty, B Dupont, 2005, Tissue antigens.

Marrow transplants from unrelated donors.

J. Hansen, E. Petersdorf, C. Anasetti, 1994, Transplantation proceedings.

HLA mismatches and hematopoietic cell transplantation: structural simulations assess the impact of changes in peptide binding specificity on transplant outcome

Mari Malkki, Chen Yanover, Philip Bradley, 2011, Immunome research.

How do amino acid mismatches affect the outcome of hematopoietic cell transplants?: a structural perspective

Chen Yanover, Philip Bradley, Mari Malkki, 2010, BCB '10.

Re: An approach to predicting HSCT outcome using HLA-mismatch information mapped on protein structure data.

M. Horowitz, Stephanie J. Lee, M. Malkki, 2010, Biology of Blood and Marrow Transplantation.

MICA, a gene contributing strong susceptibility to ankylosing spondylitis

P. Scheet, J. Reveille, E. Mignot, 2013, Annals of the rheumatic diseases.

HLA-DQ Heterodimers in Hematopoietic-Cell Transplantation.

S. Spellman, E. Petersdorf, T. Gooley, 2022, Blood.

HLA and marrow transplants from unrelated donors

J. Hansen, E. Petersdorf, C. Anasetti, 1994 .

The role of HLA matching in hematopoietic cell transplantation.

T Sasazuki, T. Sasazuki, J. Hansen, 1999, Reviews in immunogenetics.

Genetic variation in CXCL12 and risk of cervical carcinoma: a population‐based case–control study

L. P. Zhao, S. Schwartz, M. Malkki, 2009, International journal of immunogenetics.

Comparison of statistics in association tests of genetic markers for survival outcomes

Tao Wang, Franco Mendolia, John P Klein, 2014, Statistics in medicine.

Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation

R. Strong, K. Hsu, M. Malkki, 2023, Blood advances.

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

J. Klein, M. Horowitz, Stephanie J. Lee, 2006 .

Original Article Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal women

M. Malkki, E. Petersdorf, C. Bodelón, 2013 .

Missing killer immunoglobulin-like receptor (KIR) ligand confers protection from relapse in recipients of unrelated hematopoietic cell transplantation (HCT) for AML

K. Hsu, M. Malkki, E. Petersdorf, 2005 .

P047 Analysis of 25,000 Caucasian samples reveals tight linkage between SNP rs9277534 and high resolution typing of HLA-DPB1

V. Lange, E. Petersdorf, K. Lang, 2016 .

What do patients think about palliative care? A national survey of hematopoietic stem cell transplant recipients

W. Wood, A. El-Jawahri, T. Leblanc, 2021, Blood advances.

Allogeneic marrow transplantation: the Seattle experience.

J. Hansen, E. Petersdorf, C. Anasetti, 1993, Clinical transplants.

Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

K. Sullivan, J. Sierra, R. Storb, 1997, Blood.

J. Sierra, R. Storb, B. Storer, 2000, Bone Marrow Transplantation.

The HLA Complex in Biology and Medicine: A Resource Book

E. Petersdorf, 2011, Bone Marrow Transplantation.

Of genes, blocks, and haplotypes.

E. Petersdorf, 2012, Biology of Blood and Marrow Transplantation.

Effect of HLA-DRB1 and DQB1 allele disparity on the development of acute graft versus host disease following unrelated donor marrow transplantation

G. Longton, Anajane G. Smith, J. Hansen, 1994 .

Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation - A Single Center Experience.

B. Sandmaier, E. Petersdorf, L. Connelly-Smith, 2023, Transplantation and cellular therapy.

Genetic variation in CXCL12 and risk of cervical carcinoma: a population‐based case–control study

M. Malkki, E. Petersdorf, M. Madeleine, 2009, International Journal of Immunogenetics.

HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.

A. Nademanee, M. Horowitz, S. Spellman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.

K. Hsu, M. Malkki, S. Spellman, 2010, Blood.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

W. Wood, A. Gratwohl, M. Aljurf, 2014, Blood.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

M. Horowitz, J. Wingard, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

H. Deeg, J. Radich, R. Storb, 2002, Blood.

HLA Haplotypes and Relapse After Hematopoietic Cell Transplantation

M. Malkki, S. Spellman, E. Petersdorf, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

R. Apps, A. Velardi, K. Hsu, 2014, Blood.

Genetics of graft-versus-host disease: the major histocompatibility complex.

E. Petersdorf, 2013, Blood reviews.

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Multiple Myeloma : An Evidenced-Based Review

R. Kyle, J. Wingard, P. McCarthy, 2022 .

E. Petersdorf, A. Balduzzi, F. Appelbaum, 1995, Blood.

Hla-c Expression Levels Define Permissible Mismatches in Hematopoietic Cell Transplantation Key Points

M. Horowitz, E. Petersdorf, T. Gooley, 2022 .

Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantation.

G. Longton, J. Hansen, A. Smith, 1993, Transplantation proceedings.

Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.

D. Neuberg, K. Sullivan, E. Petersdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic Graft-Versus-Host Disease Risk Score: A CIBMTR Analysis

M. Horowitz, J. Wingard, R. Gale, 2010 .

Donor KIR3DL1 and HLA-B Allotypes Control Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

E. Reed, K. Hsu, M. Malkki, 2012 .

J. Panse, M. Maris, R. Storb, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.